Ligands modified by circular permutation as agonists and antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 7, 2016
Grant Date -
Dec 19, 2013
app pub date -
Jun 6, 2013
filing date -
Jun 8, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides fusion polypeptides comprising polypeptide ligands that are modified by circular permutation and fused to at least one polypeptide fusion partner wherein such fusion polypeptides have new, improved or enhanced biological functions or activities. Such improvements include, but are not limited to, increased binding affinity, increased activity, increased agonist activity (super agonist), antagonist activity, increased accessibility, increased flexibility of the active site, increased stability, broader and/or changed substrate specificity, and combinations thereof.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully